SBFM – sunshine biopharma inc. (US:NASDAQ)

News

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus [Yahoo! Finance]
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus
Sunshine Biopharma, Inc. (NASDAQ: SBFM) had its "buy" rating re-affirmed by analysts at Aegis. They now have a $15.00 price target on the stock.
Sunshine Biopharma Launches a New Generic Prescription Drug
Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com